Clinical Decision Support (CDS) Market, By Product (Diagnostic CDS and Therapeutics CDS), By Application (Drug Allergy Alert, Drug-Drug Interaction, Clinical Reminder, Clinical Guideline, and Drug Dosing Support), and By Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) - Trends, Analysis and Forecast till 2034

Report Code: PMI341719 | Publish Date: May 2024 | No. of Pages: 170

Global Clinical Decision Support Market Size

Clinical Decision Support (CDS) Market is expected to reach US$ 3.6 billion by 2034, growing at a compound annual growth rate (CAGR) of 7.8% from its 2024 valuation of US$ 1.8 billion.

The clinical decision support market is the industry that develops and provides tools and technology to assist healthcare providers in making well-informed decisions about patient care and safety. These systems integrate information from various sources, such as operating procedures, medical literature, practice guidelines, and patient records, to give medical professionals evidence-based counsel, suggestions, and recommendations that will aid in making the best choice for the parties involved. The market for clinical decision support systems is expected to expand in the following years due to the increasing use of healthcare technologies. The expansion of the CDS market is due to the increased awareness of patient safety and protection in the healthcare industry, as it can provide the medical professionals who follow guidelines and policies to protect patients from potential harm.

One of the key drivers of the Clinical Decision Support (CDS) Market's expansion and development is the integration of Electronic Health Records (EHRs). Electronic Health Records (EHRs) are computerized files containing patient data, including test results, medication prescriptions, medical history, and future treatment plans. When these records are integrated with CDS systems, anyone can receive medical alerts and reminders, helping to avert unfavorable situations and incidents in the future.